Prevalence of Mast Cell Activation Syndrome in Patients With EDS With Digestive Disorders

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

September 28, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

March 31, 2026

Conditions
Ehlers Danlos Hypermobile Syndrome
Interventions
OTHER

Determine the presence of mast cell activation syndrome

"Mast cell activation syndrome will be confirmed if the following three conditions are met (according to Valent et al, 2012) :~* At least two clinical signs compatible with MAS before the first consultation (V1)~* Improvement of symptoms on antihistamines within 2 months of initiation of treatment~* Significant increase in tryptase during crisis~Mast cell activation syndrome will be possible if :~* At least two clinical signs consistent with MAS before the first consultation (V1)~* Improvement of symptoms with antihistamines within 2 months of initiation of treatment~* No significant increase in tryptase during crisis In all other cases, mast cell activation syndrome is unlikely."

Trial Locations (1)

59020

RECRUITING

Saint-Vincent-de-Paul hospital, Lille

All Listed Sponsors
lead

Lille Catholic University

OTHER